Electrochemical therapy (ECT), also known as Galvano therapy, uses low-level direct electrical current applied directly to tumors to induce localized tissue destruction. It is a minimally invasive option for treating accessible solid tumors.
ECT works by inserting thin electrode needles into or around a tumor and passing a low-level direct current between them. The electrical current causes electrochemical reactions within the tumor tissue, including changes in pH, production of toxic chlorine and sodium hydroxide at the electrodes, and disruption of the cellular environment. These reactions destroy tumor cells in the treated area.
Under local anesthesia or mild sedation, thin platinum electrodes are placed into or adjacent to the tumor using imaging guidance. A controlled direct current is applied for a defined duration, typically at low amperage. The treatment is monitored in real time. The electrochemical reactions gradually destroy the tumor from within, and the body then absorbs the treated tissue over the following weeks.
CES is a gentle, well-tolerated treatment that may complement other therapies. Our specialists will assess whether it is appropriate for your condition
An ECT session typically lasts 1-3 hours depending on tumor size and location. The procedure is performed with local anesthesia and is generally well tolerated. Most patients can return to normal activities shortly after treatment. Multiple sessions may be required for larger tumors.
ECT has been studied in clinical research since the 1970s and is used at specialized cancer centers worldwide. Published literature includes clinical studies demonstrating tumor regression in various cancer types. The therapy has a favorable safety profile with minimal systemic side effects due to its localized mechanism of action.
Contact our neuromodulation team to discuss whether cranial electrotherapy stimulation may support your treatment.
